Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from From Platelet Toxicity to Precision Targeting: Evolving Strategies to Overcome Thrombocytopenia in BCL‐2/BCL‐XL Inhibition. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1155/2012/524308
10.1155/2012/524308 · External reference
10.3389/fonc.2022.985363
10.3389/fonc.2022.985363 · External reference
10.3389/fphar.2019.00697
10.3389/fphar.2019.00697 · External reference
10.1158/2767-9764.crc-25-0096
10.1158/2767-9764.crc-25-0096 · External reference
10.3390/cells13060528
10.3390/cells13060528 · External reference
10.3390/ijms21207591
10.3390/ijms21207591 · External reference
10.1038/s41419-025-08205-8
10.1038/s41419-025-08205-8 · External reference
10.1186/s12916-026-04671-9
10.1186/s12916-026-04671-9 · External reference
10.1038/sj.cdd.4402081
10.1038/sj.cdd.4402081 · External reference
10.1200/jco.2010.31.6208
10.1200/jco.2010.31.6208 · External reference
10.1182/blood-2011-03-344812
10.1182/blood-2011-03-344812 · External reference
10.3390/molecules27248828
10.3390/molecules27248828 · External reference
10.1016/j.ejmech.2020.112186
10.1016/j.ejmech.2020.112186 · External reference
10.3390/molecules30102123
10.3390/molecules30102123 · External reference
10.1101/2024.02.27.582353
10.1101/2024.02.27.582353 · External reference
10.1038/s41591-019-0668-z
10.1038/s41591-019-0668-z · External reference
10.3324/haematol.2022.281915
10.3324/haematol.2022.281915 · External reference
Targeting BCL‐xL to Eliminate Chemotherapy‐Induced Tumor Dormancy and Prevent Breast Cancer Metastasis: Translational Therapeutics
2025 · External reference
10.37349/etat.2020.00017
10.37349/etat.2020.00017 · External reference
10.1021/acsmedchemlett.9b00568
10.1021/acsmedchemlett.9b00568 · External reference
10.1182/blood.v112.11.3177.3177
10.1182/blood.v112.11.3177.3177 · External reference
10.1111/bjh.12457
10.1111/bjh.12457 · External reference
10.1002/ijc.29009
10.1002/ijc.29009 · External reference
10.1021/acs.jmedchem.5c03330
10.1021/acs.jmedchem.5c03330 · External reference
10.1016/j.ejmcr.2026.100332
10.1016/j.ejmcr.2026.100332 · External reference
10.3389/fmolb.2024.1505255
10.3389/fmolb.2024.1505255 · External reference
10.1080/17460441.2024.2415310
10.1080/17460441.2024.2415310 · External reference
10.1038/s41591-019-0668-z
10.1038/s41591-019-0668-z · External reference
10.1016/j.ejmech.2020.112186
10.1016/j.ejmech.2020.112186 · External reference
10.1182/blood-2019-125820
10.1182/blood-2019-125820 · External reference
10.1182/blood-2018-99-114762
10.1182/blood-2018-99-114762 · External reference
10.1186/s13045-025-01753-8
10.1186/s13045-025-01753-8 · External reference
10.1182/blood-2023-178813
10.1182/blood-2023-178813 · External reference
10.1101/2025.06.24.661170
10.1101/2025.06.24.661170 · External reference
10.1186/s13045-020-00928-9
10.1186/s13045-020-00928-9 · External reference
10.1002/cbic.202100689
10.1002/cbic.202100689 · External reference
10.1182/blood-2023-184887
10.1182/blood-2023-184887 · External reference
10.1158/1538-7445.am2025-ct063
10.1158/1538-7445.am2025-ct063 · External reference
Abstract B004: Phase 1b Trial of BCL‐xL Degrader DT2216 and Weekly Paclitaxel in Recurrent Platinum‐Resistant Ovarian Cancer
10.1158/1535-7163.targ-25-b004 · 2025 · External reference
10.1016/j.cell.2007.01.037
10.1016/j.cell.2007.01.037 · External reference
10.7150/thno.75421
10.7150/thno.75421 · External reference
10.1016/j.xcrp.2025.102593
10.1016/j.xcrp.2025.102593 · External reference
10.3390/ijms26030988
10.3390/ijms26030988 · External reference
10.1002/advs.202101454
10.1002/advs.202101454 · External reference
10.1002/cbic.202100689
10.1002/cbic.202100689 · External reference
10.1158/1078-0432.ccr-23-1525
10.1158/1078-0432.ccr-23-1525 · External reference
10.1038/s42003-020-01631-8
10.1038/s42003-020-01631-8 · External reference
10.1182/blood.2020008017
10.1182/blood.2020008017 · External reference
10.1016/j.drudis.2014.12.012
10.1016/j.drudis.2014.12.012 · External reference
10.3390/cancers17162628
10.3390/cancers17162628 · External reference
10.1016/j.smaim.2025.07.004
10.1016/j.smaim.2025.07.004 · External reference
10.3390/molecules28104014
10.3390/molecules28104014 · External reference
10.1186/s13046-020-01672-1
10.1186/s13046-020-01672-1 · External reference
10.7554/elife.92889.3
10.7554/elife.92889.3 · External reference
10.2147/dddt.s299591
10.2147/dddt.s299591 · External reference
10.2147/jbm.s80646
10.2147/jbm.s80646 · External reference
Romiplostim as a Treatment for Immune Thrombocytopenia: A Review
2015 · External reference
10.1182/blood.v118.21.1133.1133
10.1182/blood.v118.21.1133.1133 · External reference
10.1182/blood.v122.21.3504.3504
10.1182/blood.v122.21.3504.3504 · External reference
10.1056/nejme1810815
10.1056/nejme1810815 · External reference
10.1182/blood-2011-04-347849
10.1182/blood-2011-04-347849 · External reference
10.3389/fimmu.2024.1409461
10.3389/fimmu.2024.1409461 · External reference
10.1158/0008-5472.can-12-1365
10.1158/0008-5472.can-12-1365 · External reference
10.18632/aging.204207
10.18632/aging.204207 · External reference
10.1182/bloodadvances.2024013194
10.1182/bloodadvances.2024013194 · External reference
10.1038/s41419-021-04262-x
10.1038/s41419-021-04262-x · External reference
10.1158/1538-7445.am2013-1737
10.1158/1538-7445.am2013-1737 · External reference
10.1158/1535-7163.targ-13-c250
10.1158/1535-7163.targ-13-c250 · External reference
10.1158/1538-7445.am2020-6223
10.1158/1538-7445.am2020-6223 · External reference
10.7717/peerj.144
10.7717/peerj.144 · External reference
10.18632/oncotarget.5505
10.18632/oncotarget.5505 · External reference
10.1182/blood-2023-180190
10.1182/blood-2023-180190 · External reference
10.1038/s41420-022-01296-8
10.1038/s41420-022-01296-8 · External reference
10.1158/1535-7163.mct-24-0873
10.1158/1535-7163.mct-24-0873 · External reference
10.1126/sciadv.abn6579
10.1126/sciadv.abn6579 · External reference
10.1042/bst20210750
10.1042/bst20210750 · External reference
10.1126/science.1133289
10.1126/science.1133289 · External reference
10.1101/gad.215871.113
10.1101/gad.215871.113 · External reference
10.1101/gad.215855.113
10.1101/gad.215855.113 · External reference
10.1152/physiolgenomics.00173.2013
10.1152/physiolgenomics.00173.2013 · External reference
10.1097/01.cot.0000546176.37345.77
10.1097/01.cot.0000546176.37345.77 · External reference
10.1038/s42003-020-0868-6
10.1038/s42003-020-0868-6 · External reference
10.37349/etat.2020.00017
10.37349/etat.2020.00017 · External reference
10.1200/jco.2020.38.15_suppl.3509
10.1200/jco.2020.38.15_suppl.3509 · External reference
10.1200/jco.2018.36.15_suppl.2594
10.1200/jco.2018.36.15_suppl.2594 · External reference
10.1021/acs.jmedchem.1c00517
10.1021/acs.jmedchem.1c00517 · External reference
10.15212/amm-2022-0022
10.15212/amm-2022-0022 · External reference
10.1016/j.coph.2022.102310
10.1016/j.coph.2022.102310 · External reference
